Active Energy Group PLC

“The Company intends to raise up to £346,180...through the Placing...of up to 346,180,628 new Ordinary Shares...The Placing Shares, assuming full take-up, will represent approximately 68.1 per cent. of the Enlarged Issued Share Capital”

Placing at 0.1p (66.6% discount to closing price) with new shares representing 68% of enlarged capital. Proceeds of only £346k, a trivially small raise that disproportionately dilutes existing holders. [Severity adjusted: discount alone insufficient for high severity without compounding factors.]

Proposed Placing to raise approximately £2.5m

THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO .  596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED .  UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN . THIS ANNOUNCEMENT, INCLUDING THE APPENDICES TO THIS ANNOUNCEMENT, AND THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN …

Proposed Placing and BTC Focused Treasury Policy

THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO . 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED . UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN . THIS ANNOUNCEMENT, INCLUDING THE APPENDICES TO THIS ANNOUNCEMENT, AND THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PA…

Winterflood announces strategic partnership with Edison Group. Edison will provide research on WRAP transactions. Joe Winkley (Head of Corporate Services, Winterflood) quoted: 'will significantly increase the attractiveness of WRAP fundraises to investors'. Neil Shah (Edison) quoted: 'a genuinely differentiated route to market'.

Delighted to have advised Andrew Webb et al on this latest raise. 2026 will be a very exciting year for CRISM Therapeutics as it kicks off Phase 2 trial. Retail offer now live on BookBuild.

Broker personnel promoting active retail offer on personal LinkedIn

POATR era has begun. Joint open letter from AJ Bell, Hargreaves Lansdown, interactive investor, and RetailBook CEOs to Chancellor. RetailBook led the effort (Stacey Parsons).

RetailBook positioning itself as market leader and lobbying for retail-inclusive IPOs alongside major platforms

Podcast featuring Paul Elliott (Active Energy CEO) discussing Bitcoin treasury strategies alongside Scott Ellam (Connecting Excellence) and Leon Coetzer (Jubilee Metals).

CEO actively promoting BTC treasury strategy on podcast circuit

Major milestone for institutional crypto in the UK. Satsuma Technology closed £100m+ fundraise. Lists Cel AI (#CLAI) among wave of London-listed firms embedding Bitcoin into corporate treasury strategy alongside SWC, V3TC, BTC (Vinanz).

Bitcoin treasury cluster being actively promoted on LinkedIn — same issuers appearing across WRAP (SWC, Vinanz) and BookBuild (Cel AI, Active Energy)

CleanTech Lithium opens retail share offer via BookBuild at 5p/share alongside £4.3m placing. Retail offer oversubscribed, raising £250,000.

Proactive Investors shared article on LinkedIn. The placing price of 5p represented significant dilution from earlier raises at 16p. Company had noteholder forced review. No LinkedIn posts found from CleanTech Lithium's own company page or CEO Aldo Boitano specifically promoting the BookBuild retail offer, though the company page shares operational updates regularly.

CEO/Chair personal LinkedIn post about J&J partnership for POLB 001 clinical trial. Describes 'exciting update' and 'good news'. Johnson & Johnson providing multi-million euro drug supply free of charge. 126 reactions on company repost.

Cathal Friel uses personal LinkedIn to promote clinical developments during fundraise period. While this specific post is about a clinical partnership rather than the fundraise itself, it creates positive sentiment during an active BookBuild retail offer window. No risk warnings. Friel is a serial AIM entrepreneur (Open Orphan/hVIVO, Amryt).

Proactive Investors posted a LinkedIn video titled 'Zephyr Energy CEO on share placing, Paradox and Rocky...' discussing the company's share placing alongside its Paradox project and Rocky Mountain operations. Separately, references to a £3.15m equity placing and a crypto mining venture near its Paradox Basin operations were found. The crypto mining project would give Zephyr a bitcoin-adjacent revenue stream.

LinkedIn post URL: linkedin.com/posts/proactive-investors_zephyr-energy-ceo-on-share-placing-paradox-activity-7343619299841892355. Bitcoin treasury angle not explicitly confirmed in LinkedIn posts but crypto mining venture is documented. Cyber incident adds governance concern.

Savannah Resources' own LinkedIn page and Proactive Investors posted about multiple fundraises: a £9.2m oversubscribed placing and subscription (scaled back from higher demand), a £6.5m fundraise at market price made available to private investors via PrimaryBid (July 2023), a £6.1m placing and subscription, and a further £1m placing to a major shareholder. The retail offer component via PrimaryBid was highlighted as providing retail shareholder access. CEO also discussed Barroso lithium project funding on Proactive.

LinkedIn posts from company page: linkedin.com/company/savannah-resources-plc. Proactive post: linkedin.com/posts/proactive-investors_savannah-resources-ceo-outlines-way-forward-activity-7348705237223833601. Pattern of repeat raises with PrimaryBid retail component is consistent with the 'repeat raises' concern.

Faron Pharmaceuticals' LinkedIn page and Proactive Investors referenced a €7.1m share offering (late October 2024) and a larger February 2025 accelerated bookbuild placing that was 1.8x oversubscribed, raising EUR 12m (upsized from EUR 10m target). 6,976,744 shares issued at EUR 1.72. The placing was explicitly designed to address financial covenant requirements. Company acknowledged that without the raise, it could not meet minimum cash covenants agreed with lender IPF.

Faron LinkedIn: linkedin.com/company/faron. Post about new CFO: fi.linkedin.com/posts/faron_faron-pharmaceuticals-moving-into-next-phase-activity-7049404979370958848. The covenant breach risk is well-documented in RNS but LinkedIn posts from the company itself do not highlight this risk prominently.

Matthew Moulding's LinkedIn profile shows active posting about THG's transformation. Moulding personally spent £39m since IPO to increase his stake (most recently £5m at 39p in late 2022). Kelso Group Holdings posted about purchasing 5.0m THG shares at 54.5p average (0.4% of THG). No LinkedIn posts specifically detailing the £90m raise or Moulding's £60m contribution to that raise were found. Posts focus on value narrative, Ingenuity demerger potential, and FT media criticism.

Moulding profile: linkedin.com/in/matthew-moulding-b131929. The £60m of £90m raise detail was not found in LinkedIn posts specifically - may be documented in RNS/press only. LinkedIn posts from Moulding are defensive/narrative-driven, criticising PE approaches and media coverage.

CelLBxHealth PLC (AIM:CLBX, formerly ANGLE) plans to raise £6.8 million through a share placing, subscription and separate offer for private shareholders at 1p per share. Also proposes share capital reorganisation splitting each 10p share into a new ordinary share (0.05p) and a deferred share (9.95p).

Posted by Proactive Investors (financial media). No risk warnings present despite significant capital restructuring. Does not mention 68% dilution figure or RetailBook/BookBuild involvement. Zero engagement suggests limited reach. URL: https://www.linkedin.com/posts/proactive-investors_cellbxhealth-plans-68-million-fundraise-activity-7398990897075511296-PAKt

MicroSalt PLC debuted on AIM with £18.5m valuation, raising £3m. Shares at 43p under SALT ticker. CEO Rick Guiney quoted on successful fundraise. Shares up 20% to 52p by Friday.

News coverage of IPO. Factual reporting with CEO quote. No risk warnings.